Skip to main content
OpenTrials
Completed

NCT Number: NCT02866539

Effect of Polyherbal Compound for Control of Blood Sugar in Impaired Glucose Tolerance and Diabetes

The aim of the study is to control blood sugar with Sugar Balance capsules which is the leaves of three herbs: ivy ground (Coccinia indica)-200mg, bougainvillia (Bougainvillea spectabilis)-30mg, Madagascar periwinkle (Catharanthus rosea)-20mg.

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Narayana Hrudayalaya Limited, Mazumdar Shaw multispecialty Hospital

Bangalore, Karnataka, 560099, India

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult males and non-pregnant females aged ≥30 years having a diagnosis of pre-diabetes (impaired fasting glucose or impaired glucose tolerance) and a diabetes and a meeting one of the following criteria
  • Fasting Plasma Glucose ≥100 mg/dL, fasting is defined as no caloric intake for at least 8 h, OR
  • 2-h Post load Glucose ≥140 mg/dL during an Oral Glucose Tolerance Test (OGTT). The test should be performed as described by the World Health Organisation(WHO), using a glucose load containing the equivalent of 75 g anhydrous glucose dissolved in water. OR
  • Glycosylated haemoglobin (A1C) ≥5.7%. The test should be performed in a laboratory using a method that is National Accreditation Board for Testing and Calibration Laboratories certified and standardized. OR
  • In a patient with classic symptoms of hyperglycaemia or hyperglycaemic crisis, a random plasma glucose ≥200 mg/dL in the last 12 months.

Exclusion criteria

  • Any one of the following
  • History of diabetes onset >12 months from date of randomization and/or on any oral hypoglycemic agents (other than metformin)
  • Any history suggestive of micro vascular or macro vascular disease
  • Women in childbearing age unable to practice any form of contraception
  • Impaired renal function; estimated glomerular filtration rate(eGFR) <60mls/min/1.73m2.
  • Known history of any chronic illness taking regular pharmacological agents.
  • Blood pressure fluctuations exceeding 10 mmHg on 2 subsequent clinic visits or known history of hypotension or bradycardia in last 6 months or taking 2 or more antihypertensive medications regularly in the last 6 weeks
  • Current or former employees of organic India
  • Participating in another clinical trial with an active intervention or drug or device with last dose taken within 60 days.
  • Refusing consent or physician uncomfortable with patient compliance to treatments or follow up.

Treatment and study plan

Polyherbal capsule coccinia, bougainvillea, catharanthus

Drug

A unique combination of 3 herbs that lower blood sugars

Other names: Sugar Balance (SB)

Placebo

Drug

Similar looking inactive powder

Primary outcomes

  1. Number of diabetes subjects achieving glycemic control

    Time frame: 6 months

    a 0.5% reduction in baseline A1c and/or fasting plasma glucose below 125 mg/dl or 2 hour postprandial glucose <180 mg/dl

  2. Number of pre-diabetes achieving euglycemic status

    Time frame: 6 months

    measured as A1c < 5.7% and/or fasting plasma glucose <100mg/dl/

Sponsors and collaborators

Lead sponsor

Composite Interceptive Med Science

Industry

Registry information

Official study title

A Polyherbal for Control of Blood Sugar in Subjects With Impaired Glucose Tolerance and/or Early Type 2 Diabetes. A Randomized Placebo Controlled Study of a Polyherbal (Whole Herb Formulation)

Important dates

Study start
2016
Primary completion
2017
Study completion
2018
First posted
Aug 15, 2016
Registry last updated
Apr 11, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.